These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19620150)

  • 1. ACP Journal Club. Review: Blood pressure-lowering treatments reduce CV morbidity and mortality in patients receiving dialysis.
    Harnett J
    Ann Intern Med; 2009 Jul; 151(2):JC1-6. PubMed ID: 19620150
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk.
    Muñoz D; Granger CB
    Ann Intern Med; 2012 Apr; 156(8):JC4-07. PubMed ID: 22508747
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: statins decrease mortality and major CV events in adults with CKD not receiving dialysis.
    Ramesh Prasad GV
    Ann Intern Med; 2012 Nov; 157(10):JC5-4. PubMed ID: 23165680
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Review: lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD.
    Ramesh Prasad GV
    Ann Intern Med; 2012 Nov; 157(10):JC5-5. PubMed ID: 23165681
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure.
    Singh V
    Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club: Review: Low BP targets do not reduce mortality or CV events in hypertension.
    McAlister FA
    Ann Intern Med; 2009 Nov; 151(10):JC5-6-7. PubMed ID: 19920264
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Review: Intensive glucose lowering does not reduce mortality in type 2 diabetes.
    Lingegowda V
    Ann Intern Med; 2011 Dec; 155(12):JC6-4. PubMed ID: 22184705
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Review: Counseling and educational methods that target multiple CV risk factors do not reduce mortality in adults without CHD.
    Patel MJ; Newby LK
    Ann Intern Med; 2011 Jun; 154(12):JC6-4. PubMed ID: 21690582
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.
    Shantsila A; Lip GY
    Ann Intern Med; 2009 Aug; 151(4):JC2-11. PubMed ID: 19687485
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD.
    Poirier P
    Ann Intern Med; 2009 Oct; 151(8):JC4-5. PubMed ID: 19841443
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Review: Current drug treatments do not reduce mortality in idiopathic pulmonary fibrosis.
    Lipchik RJ
    Ann Intern Med; 2011 Jun; 154(12):JC6-8. PubMed ID: 21690586
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Review: Aspirin does not reduce CV events but may reduce nonfatal stroke in peripheral artery disease.
    Mukherjee D
    Ann Intern Med; 2009 Sep; 151(6):JC3-5, JC3-4. PubMed ID: 19755351
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Review: first-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension.
    Shah NR; Ogedegbe G
    Ann Intern Med; 2010 Jan; 152(2):JC1-4. PubMed ID: 20083819
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors.
    Farkouh M
    Ann Intern Med; 2010 Jun; 152(12):JC6-10. PubMed ID: 20547892
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-04, JC4-05. PubMed ID: 22508744
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes.
    Lipscombe LL
    Ann Intern Med; 2009 Sep; 151(6):JC3-6. PubMed ID: 19755352
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes.
    Lipscombe L
    Ann Intern Med; 2009 Apr; 150(8):JC4-8. PubMed ID: 19391221
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Glargine did not reduce CV events more than standard care in patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-10, JC3-11. PubMed ID: 22986402
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. Multifactorial cardiac rehabilitation did not reduce mortality or morbidity after acute myocardial infarction.
    Franklin BA
    Ann Intern Med; 2012 Jul; 157(2):JC2-11. PubMed ID: 22801702
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-11. PubMed ID: 22986403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.